Latest Interest Expense News

Matrix Composites & Engineering has fully redeemed its $7.5 million convertible note, replacing it with a new term loan facility from NAB that offers improved terms and a streamlined debt structure.

Atomos Limited has exercised 259.8 million options, raising $7.8 million to reduce its debt and boost confidence in hitting $23–25 million sales and positive EBITDA in the first half of 2026.

Reece Limited reported an 8% rise in first-quarter sales driven by network expansion, while profitability dipped due to higher costs and investments. The company also completed a $365 million share buyback, signaling confidence despite subdued market conditions.

5E Advanced Materials reports progress on its California boron project with a new feasibility study and equity raises, while highlighting ongoing funding uncertainties.

Wisr Limited has refinanced its corporate debt facility, lowering interest expenses and reducing drawn debt, setting the stage for cash NPAT profitability in the second half of FY2026.

Range International has completed a significant capital raise of A$1.58 million through a two-tranche placement, positioning itself for growth in Indonesia and the Philippines while reducing debt.

Epsilon Healthcare has posted its highest-ever quarterly receipts of $2.919 million, reflecting a robust turnaround since exiting voluntary administration in mid-2024. The company’s strategic sale and leaseback deal has also enabled significant debt reduction, setting the stage for sustained growth.

Amcor’s first quarter fiscal 2026 results showcase strong growth driven by the Berry Global acquisition, with sales up 68% and synergies exceeding expectations. The company also raised its dividend and reaffirmed its full-year guidance.

Aeris Resources has secured $80 million through an institutional placement and launched a $10 million share purchase plan, aiming to repay debt and accelerate key exploration projects.

Visionflex Group has converted $3.25 million of debt into equity at a 100% premium, emerging debt-free and poised for growth. The company’s Q1 FY26 results show a 34% increase in annual recurring revenue, supported by new product launches targeting the expanding virtual healthcare market.

TZ Limited reports steady sales growth and new Microsoft contracts in Q1 FY2026, reaffirming its $17–21 million revenue guidance amid improving market conditions.

Renergen Limited forecasts a significant rise in loss per share for H1 2025, driven by one-off transaction costs and full commissioning expenses. The company’s updated trading statement reveals losses could nearly double compared to last year.